ZWS (ZWS) Stock Analysis
Verdict: HOLD
High gross margins and clean balance sheet justify a premium, but weak 30-day price momentum and insider selling cap near-term upside.
Investment score: 58/100
Zurn Elkay boasts industry-leading gross margins (44.8%) and strong balance sheet health (D/E 0.33), but trades at a premium P/E of 27.9x vs peer median of 22.0x while suffering from technical momentum weakness (-12.3% in 30 days) and insider distribution.
Peers
| Peer | P/E | P/B | P/S | EV/EBITDA | ROIC % | Net margin % |
|---|---|---|---|---|---|---|
| LII | 16.34 | 9.70 | 2.36 | 12.77 | — | 0.15 |
| MAIR | 109.03 | 3.07 | 6.24 | 32.48 | — | 0.05 |
| WMS | 21.96 | 5.26 | 3.05 | 12.32 | — | 0.14 |
| OC | -15.76 | 2.73 | 1.05 | 23.15 | — | -0.07 |
| MOD | 70.17 | 8.42 | 2.95 | 34.74 | — | 0.04 |